Abstract

The trade group for the US pharmaceutical industry has warned that President Donald Trump’s latest executive order calling for essential drugs to be manufactured in the US will stifle innovation....

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Future Implications of the Buy American-Hire American Executive Order and Domestic Preferences on U.S. Government Procurement and Trade Policies
Marlene Milgram
SSRN Electronic Journal | VOL. -
Marlene MilgramMarlene Milgram
23 Jul 2018
Ten Thousand Commandments: An Annual Snapshot of the Federal Regulatory State (2020 Edition)
SSRN Electronic Journal | VOL. -
15 Sep 2020
Essays on skilled-labor immigration and economic mobility
Urbashee U Paul
-
Urbashee U PaulUrbashee U Paul
24 Aug 2022
It's a Full Moon Tonight: Speaker Meaning and the Interpretation and Construction of Executive Orders (with Related Reflections on Legislative Speaker Meaning)
Harold Anthony Lloyd
SSRN Electronic Journal | VOL. -
Harold Anthony LloydHarold Anthony Lloyd
07 Sep 2017
View more papers

More From: BMJ

Paper Title
Journal
Date
Author
New WHO guidance can support transparent and informed engagement with the private sector
Kent Buse ... Monika Arora
BMJ | VOL. 385
Kent Buse, et. al.Kent Buse ... Monika Arora
29 May 2024
Labour’s pledge to clear NHS waiting list within five years will be tough to achieve, say leaders
Matthew Limb
BMJ | VOL. 385
Matthew LimbMatthew Limb
29 May 2024
Sudan: Aid workers describe “bloodbath” in Darfur as hospitals are repeatedly attacked
Elisabeth Mahase
BMJ | VOL. 385
Elisabeth MahaseElisabeth Mahase
29 May 2024
US state classifies mifepristone and misoprostol as dangerous controlled substances
Janice Hopkins Tanne
BMJ | VOL. 385
Janice Hopkins TanneJanice Hopkins Tanne
29 May 2024
View more papers